0001654954-23-013894.txt : 20231108 0001654954-23-013894.hdr.sgml : 20231108 20231108090410 ACCESSION NUMBER: 0001654954-23-013894 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20231108 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231108 DATE AS OF CHANGE: 20231108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KNOW LABS, INC. CENTRAL INDEX KEY: 0001074828 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 900273142 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37479 FILM NUMBER: 231386248 BUSINESS ADDRESS: STREET 1: 500 UNION STREET STREET 2: SUITE 810 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 206-903-1351 MAIL ADDRESS: STREET 1: 500 UNION STREET STREET 2: SUITE 810 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: VISUALANT INC DATE OF NAME CHANGE: 20070220 FORMER COMPANY: FORMER CONFORMED NAME: Visualant, INC DATE OF NAME CHANGE: 20050106 FORMER COMPANY: FORMER CONFORMED NAME: STARBERRYS CORP DATE OF NAME CHANGE: 20020918 8-K 1 knwn_8k.htm FORM 8-K knwn_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 8, 2023

 

KNOW LABS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

001-37479

 

90-0273142

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

500 Union Street, Suite 810, Seattle, Washington 

 

98101

(Address of principal executive offices)

 

(Zip Code)

 

(206) 903-1351

(Registrant's telephone number, including area code)

 

 __________________________________________________________

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.001

 

KNW

 

NYSE American LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board. Messrs. Ellingson, Cronin, and Londergan are deemed to qualify as independent under the director independence standards set forth in the rules and regulations of the SEC and applicable NYSE listing standards.

 

There are no arrangements or understandings between Messrs. Ellingson, Cronin, and Londergan and any other person pursuant to which Messrs. Ellingson, Cronin, and Londergan were selected as a director of the Company, and there are no family relationships between Messrs. Ellingson, Cronin, and Londergan and any of the Company’s Directors or executive officers. There are no transactions to which the Company is a party and in which Messrs. Ellingson, Cronin, and Londergan has a direct or indirect material interest that would be required to be disclosed under Item 404(a) of Regulation S-K, except that on August 11, 2022, the Company entered into an Intellectual Property Services Agreement with ipCapital Group, Inc., a company associated with Mr. Cronin, for professional services related to developing a more robust and valuable IP portfolio. As of the year ended September 30, 2023, the Company has paid ipCapital Group approximately $713,000 in professional fees.

 

Initial Board Committee assignments for Messrs. Ellingson, Cronin, and Londergan have not been determined at the time of this filing. This filing will be amended to include that information when available.

 

As with other non-employee directors of the Corporation, Messrs.   Ellingson, Cronin, and Londergan will each receive an annual stock option grant  under the Know Labs, Inc. 2021 Equity Incentive Plan at the end of each fiscal year and an annual cash retainer of $10,000-$12,500 as consideration for their board services.

 

Below is a description of Messrs. Ellingson, Cronin, and Londergan’s professional work experience.

 

John Cronin, 68, is an experienced inventor and intellectual property strategist. Mr. Cronin is Chairman and CEO of ipCapital Group, Inc. (“ipCG”), a globally recognized IP strategy consulting firm founded in 1998, offering more than 45 different services. Mr. Cronin has authored greater than 1,600 patents and applications across hundreds of technology spaces, leveraging the ipCapital Methodology. Before forming ipCG, Mr. Cronin spent over 17 years at IBM and became its top inventor with over 100 patents and 150 patent publications. He created and ran the IBM Patent Factory, which was essential in helping IBM become number one in US patents and led the team that contributed to the startup and success of IBM’s licensing program. Mr. Cronin is also the Chair of the Board of Directors of AdrenalineIP, Chairman of IX-Innovations, and is the Founder of HarvestWeb, a 501(c)3 charitable organization that provides an easy online way to make donations to food pantries.

 

Mr. Cronin has a B.S. (E.E.), an M.S. (E.E), and a B.A. degree in Psychology from the University of Vermont.

 

Timothy M. Londergan, Ph.D., 50, is a creative and results oriented business executive with 20 years of experience with early-stage technology companies. In May 2020, Mr. Londergan founded Tangibly, Inc., a company focused on helping companies manage their most valuable assets, trade secrets, through an innovative AI platform that can analyze patents and predict related trade secrets. Mr. Londergan continues to act as CEO of Tangibly, Inc. From May 2017-2021, Mr. Londergan founded and was CEO of WaveFront Venture Labs Pte Ltd, focused on helping leading Fortune 100 corporations incubate new companies based on highly promising, yet currently dormant technologies and was developing a platform to systematically evaluate and extract the most promising technologies trapped inside these companies and create paths to market for them via new company formation. WaveFront was acquired by Boustead Securities in 2021. From January 2018 to June 2020, Mr. Londergan was co-founder and CEO of Operem, Inc., a company that created blockchain based tools for managing intangible assets and was acquired by Abaxx. Mr. Londergan was recently named IAM 300 World’s Leading IP Strategist 2023.

 

Mr. Londergan has 30+ issued patents, 20+ applications along with over 20 publications in peer reviewed journals and conference proceedings.

 

 
2

 

 

Mr. Londergan holds a Ph.D. in Organic Chemistry, 1998, from the University of Southern California and a B.S. in Chemistry, 1995, from St. Bonaventure University.

 

Larry K. Ellingson, 77, holds a BS, Pharmacy, from North Dakota State University (NDSU), Fargo, North Dakota and an Executive MBA from Babson College, Babson Park, Massachusetts.

 

From April 23, 2019 to present, Mr. Ellingson has served as a member of Know Labs advisory board. From 2013 to present, Mr. Ellingson is Co-Founder of the Diabetes Leadership Council and Vice Chair Global initiatives. Since 2006 to present, Mr. Ellingson has been President of Global Diabetes Consulting LTD.

 

Mr. Ellingson retired from Eli Lilly and Company in May 2001 after having been involved as a leader of global diabetes for Lilly for more than half of his career. He has held several other positions at Lilly including Director of Pharmaceutical New Product Planning for gastrointestinal, skeletal, endocrine and infectious diseases, along with responsibility for marketed products in those areas in the late 1980’s.

 

Mr. Ellingson continues to remain active with committee work and board positions for a multitude of organizations, among them are NDSU, Research Park, International Diabetes Federation, Academy of Nutrition and Dietetics, Nurse Practitioners Healthcare Foundation and the American Diabetes Association®. His contributions to the Association have been abundant and far-reaching and have spanned over 20 years. He has held numerous positions within the Association such as member of the Industry Advisory, Strategic Marketing Task Force, Strategic Planning Task Force, Big Ticket Task Force, Pinnacle Society and the Income Development Committee. He has been Chair or Vice Chair for an equally extensive list of bodies within the Association including the Board of Directors, Fundraising Committee, Executive Committee and Nominating Committee. He has unquestionably been a positive force and an integral part of mission delivery.

 

Mr. Ellingson has been honored several times for his achievements in his field. He was honored by being the first and only non–scientist to receive Eli Lilly’s President’s Award and the Lilly Research Award for contributions to diabetes research. In 2001, Eli Lilly created the Ellingson Legacy Award to honor those who provide outstanding service to the customer. Ellingson was the first recipient of the award. The ADA, Indiana affiliate awarded Mr. Ellingson the J.K. Lilly Award in 2004 for his contributions & service to the field of diabetes. NDSU awarded him the highest honor in 2007, naming him An Outstanding Alumni of the Year for his contributions to the field and to the University. The American Diabetes Association® recognized Mr. Ellingson in 2006 with the Charles H. Best Medal for Outstanding Service for his exceptional contributions as Chair of the Board. The ADA recognized Mr. Ellingson with the prestigious Wendell Mayes Jr. Award in 2013 for his long-term service in diabetes. Mr. Ellingson received an Honorary Membership in 2020 to the Academy of Nutrition and Dietetics for his contributions to the Academy. He continues to be engaged in diabetes programs and projects through the Diabetes Leadership Council which he cofounded in 2013.

 

Item 7.01 Regulation FD Disclosure.

 

On November 8, 2023, the Company published a press release regarding the appointment of Messrs. Ellingson, Cronin, and Londergan. A copy of the press release is attached hereto as Exhibit 99.1

 

The information included in this Item 7.01 of this Current Report on Form 8-K, including the attached Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.

Description

99.1

Press release dated November 8, 2023.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
3

 

 

SIGNATURES

 

                Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 8, 2023

KNOW LABS, INC.

 

 

 

 

 

/s/ Ronald P. Erickson

 

 

Name: Ronald P. Erickson

 

 

Title: Chairman of the Board

 

 

 
4

  

 EX-99.1 2 knwn_ex991.htm PRESS RELEASE knwn_ex991.htm

EXHIBIT 99.1

 

 

  

Know Labs Expands Board of Directors

Appoints Three New Directors with Deep Sector Expertise

 

SEATTLE – November 8, 2023 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of three new members to the Company’s Board of Directors. These appointments increase the number of Directors to seven. Each new Director brings to the board extensive sector-relevant experience with deep knowledge of the science and the marketplace that is the focus of Know Labs. The new appointees are John Cronin, Larry Ellingson and Tim Londergan.

 

John Cronin is the founder and CEO of ipCapital Group, Inc., a leading global advisory company on intellectual property strategy and monetization. Cronin began his career at IBM where he was the sole inventor of breakthrough chip design technology that became the company’s most valuable patent, generating $500 million in revenue. He went on to create the IBM Patent Factory and grew IBM’s patent portfolio from ninth to number one in the world. He played a pivotal role in increasing IBM’s patent licensing revenue from $30 million to over $2 billion a year. Cronin has been a strategic advisor and consultant to Know Labs, supporting the company’s expanding patent portfolio from 86 to 246 patents issued, pending and in process over the last twelve months, increasing its global leadership in the non-invasive blood glucose monitoring category.

 

Larry Ellingson has been a member of Know Labs’ Medical Advisory Board for the past four years. Ellingson’s insight and global relationships have been instrumental in shaping Know Labs’ strategy and opening important doors in the diabetes industry. Ellingson’s background includes 30 years with Eli Lilly where he headed the multibillion-dollar annual revenue Diabetes Care business unit. Ellingson has been an advocate for accessible and affordable diagnosis and treatment through his activities with diabetes focused non-profit organizations. Among his many activities he has served as Chairman of the Board of the American Diabetes Association and has been the Vice-Chairman of the Board of the Diabetes Leadership Council for the last several years.

 

Tim Londergan is the founder and CEO of Tangibly, Inc., developer of the globe’s pre-eminent trade secret management platform. Trade secrets are a key component of an IP asset base and include the company’s proprietary algorithms. Londergan has a Ph.D. in Chemistry and experience as a CEO and COO of technology companies, including Lumera, Wavefront Venture Labs and Operem. He spent several years as Head of Commercial Development at Intellectual Ventures--a six-billion-dollar global intellectual property fund. In that role he managed a project between Intellectual Ventures and Know Labs to enhance Know Labs’ IP portfolio. Recently, Londergan was named IAM 300 World’s Leading IP Strategist 2023.

 

 

1

 

 

“We are fortunate to be able to attract to our board these respected individuals whose areas of expertise are directly related to the work we have underway,” said Ron Erickson, CEO and Chairman at Know Labs. “Their insights will help us build upon the knowledge and skills of our other board members and our own team as we refine our technology, expand our IP asset base, work on strategic collaboration opportunities, and prepare for submission and hoped-for FDA clearance of our non-invasive blood glucose monitoring device. We are thrilled to have John Cronin, Larry Ellingson and Tim Londergan join our Board of Directors.”

 

For more information on Know Labs, visit www.knowlabs.co.

 

About Know Labs, Inc.

Know Labs, Inc. is a public company whose shares trade on the NYSE American Exchange under the stock symbol “KNW.” The Company’s platform technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The technology can be integrated into a variety of wearable, mobile or bench-top form factors. This patented and patent-pending technology makes it possible to effectively identify and monitor analytes that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests. The first application of the technology will be in a product marketed as a non-invasive glucose monitor. The device will provide the user with accessible and affordable real-time information on blood glucose levels. This product will require U.S. Food and Drug Administration clearance prior to its introduction to the market.

 

Safe Harbor Statement

This release contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Know Labs, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy; and (iv) performance of products. You can identify these statements by the use of the words “may,” “will,” “could,” “should,” “would,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” “likely,” “forecast,” “probable,” “potential,” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Know Labs, Inc.’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. These risks and uncertainties also include such additional risk factors as are discussed in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended September 30, 2022, Forms 10-Q and 8-K, and in other filings we make with the Securities and Exchange Commission from time to time. These documents are available on the SEC Filings section of the Investor Relations section of our website at www.knowlabs.co. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.

 

For Know Labs Media Inquiries Contact:

Matter Health

Abby Mayo

Knowlabs@matternow.com

Ph. (617) 272-0592

 

Know Labs, Inc. Contact:

Jordyn Hujar

jordyn@knowlabs.co

Ph. (206) 629-6414

 

 

2

  

 EX-101.SCH 3 knwn-20231108.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 knwn-20231108_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer EX-101.CAL 5 knwn-20231108_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 knwn-20231108_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 knwn-20231108_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 8 knwn_ex991img2.jpg begin 644 knwn_ex991img2.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 08, 2023
Cover [Abstract]  
Entity Registrant Name KNOW LABS, INC.
Entity Central Index Key 0001074828
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Nov. 08, 2023
Entity File Number 001-37479
Entity Incorporation State Country Code NV
Entity Tax Identification Number 90-0273142
Entity Address Address Line 1 500 Union Street
Entity Address Address Line 2 Suite 810
Entity Address City Or Town Seattle
Entity Address State Or Province WA
Entity Address Postal Zip Code 98101
City Area Code 206
Local Phone Number 903-135
Security 12b Title Common Stock, par value $0.001
Trading Symbol KNW
Security Exchange Name NYSE
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
XML 10 knwn_8k_htm.xml IDEA: XBRL DOCUMENT 0001074828 2023-11-08 2023-11-08 iso4217:USD shares iso4217:USD shares 0001074828 false 8-K 2023-11-08 KNOW LABS, INC. NV 001-37479 90-0273142 500 Union Street Suite 810 Seattle WA 98101 206 903-135 false false false false Common Stock, par value $0.001 KNW NYSE false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

JQ"(6,P$ "(" / M " 4@0 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " "$2&A7)!Z; MHJT #X 0 &@ @ &H$0 >&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'-02P$"% ,4 " "$2&A799!YDAD! #/ P $P M @ &-$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" #7 %$P ! end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://knwn.com/role/Cover Cover Cover 1 false false All Reports Book All Reports knwn-20231108.xsd knwn-20231108_cal.xml knwn-20231108_def.xml knwn-20231108_lab.xml knwn-20231108_pre.xml knwn_8k.htm http://xbrl.sec.gov/dei/2023 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "knwn_8k.htm": { "nsprefix": "knwn", "nsuri": "http://knwn.com/20231108", "dts": { "schema": { "local": [ "knwn-20231108.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "knwn-20231108_cal.xml" ] }, "definitionLink": { "local": [ "knwn-20231108_def.xml" ] }, "labelLink": { "local": [ "knwn-20231108_lab.xml" ] }, "presentationLink": { "local": [ "knwn-20231108_pre.xml" ] }, "inline": { "local": [ "knwn_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://knwn.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-11-08to2023-11-08", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "knwn_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-11-08to2023-11-08", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "knwn_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 2", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://knwn.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001654954-23-013894-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-23-013894-xbrl.zip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